{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:34:10Z","timestamp":1782495250549,"version":"3.54.5"},"reference-count":102,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Acquired Immunodeficiency Syndrome (AIDS), caused by the Human Immunodeficiency Virus (HIV), is a global infectious disease that remains a significant global health challenge. Although antiretroviral therapy (ART) has significantly reduced HIV-1-related morbidity and mortality, it cannot eradicate viral reservoirs latent in host cells and long-term use of ART is also associated with issues such as drug toxicity, drug resistance, and poor patient compliance. Recent achievements in biomaterials have provided new ideas and tools for AIDS prevention, diagnosis, and treatment. Therefore, this review aims to summarize the latest research progress on biomaterials for immune cell functional regulation and immune activation strategies in HIV-1 prevention, control, and treatment. These approaches include enhancing the functions of CD8+ T cells and macrophages and synergizing with the targeted delivery and immunomodulatory capabilities of biomaterials to achieve viral clearance and immune reconstitution. Current challenges and the great potentials of biomaterials in drug delivery, vaccine development, and physical barriers for HIV-1 infection are discussed, along with future perspectives. By systematically reviewing relevant research findings, this review may provide theoretical basis and technical tools for promoting the clinical translation and application of biomaterials for HIV-1 infection.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1670423","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T05:29:46Z","timestamp":1756704586000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunomodulatory biomaterials in HIV-1 infection prevention, control and treatment"],"prefix":"10.3389","volume":"16","author":[{"given":"Jiaying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01381-8","article-title":"HIV-1 epidemiology, prevention, treatment, and implementation strategies for public health","volume":"403","author":"Mody","year":"2024","journal-title":"Lancet (London England)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","article-title":"Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet (London England)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000003344","article-title":"Updated data and methods for the 2023 UNAIDS HIV-1 estimates","volume":"95","author":"van Schalkwyk","year":"2024","journal-title":"J acquired Immune deficiency syndromes (1999)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600693","article-title":"Antiretroviral therapy for the prevention of HIV-1 transmission","volume":"375","author":"Cohen","year":"2016","journal-title":"New Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00272-2","article-title":"Longitudinal trends in causes of death among adults with HIV-1 on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies","volume":"11","author":"Trickey","year":"2024","journal-title":"Lancet HIV-1"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI171554","article-title":"The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy","volume":"133","author":"McMyn","year":"2023","journal-title":"J Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00228-X","article-title":"HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis","volume":"10","author":"Loosli","year":"2023","journal-title":"Lancet HIV-1"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7326\/M23-0788","article-title":"Demonstration project of long-acting antiretroviral therapy in a diverse population of people with HIV-1","volume":"176","author":"Gandhi","year":"2023","journal-title":"Ann Internal Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00914-1","article-title":"Prevention, treatment and cure of HIV-1 infection","volume":"21","author":"Landovitz","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00753-w","article-title":"Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies","volume":"23","author":"Haynes","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.chom.2022.01.005","article-title":"SARS-CoV-2 prolonged infection during advanced HIV-1 disease evolves extensive immune escape","volume":"30","author":"Cele","year":"2022","journal-title":"Cell Host Microbe"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd7331","article-title":"Learning the language of viral evolution and escape","volume":"371","author":"Hie","year":"2021","journal-title":"Sci (New York NY)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"112674","DOI":"10.1016\/j.msec.2022.112674","article-title":"Silk-inspired fiber implant with multi-cues enhanced bionic microenvironment for promoting peripheral nerve repair","volume":"135","author":"Chen","year":"2022","journal-title":"Biomaterials Adv"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-020-0719-0","article-title":"Role of nanoscale antigen organization on B-cell activation probed using DNA origami","volume":"15","author":"Veneziano","year":"2020","journal-title":"Nat nanotechnology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c11346","article-title":"Covalent organic frameworks: recent progress in biomedical applications","volume":"17","author":"Shi","year":"2023","journal-title":"ACS nano"},{"key":"B16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat Rev Materials"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-023-01472-w","article-title":"Hydrogels for RNA delivery","volume":"22","author":"Zhong","year":"2023","journal-title":"Nat materials"},{"key":"B18","doi-asserted-by":"publisher","first-page":"122528","DOI":"10.1016\/j.biomaterials.2024.122528","article-title":"Progress in the development of piezoelectric biomaterials for tissue remodeling","volume":"307","author":"Nain","year":"2024","journal-title":"Biomaterials"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e2313672","DOI":"10.1002\/adma.202313672","article-title":"Multifunctional conductive and electrogenic hydrogel repaired spinal cord injury via immunoregulation and enhancement of neuronal differentiation","volume":"36","author":"Liu","year":"2024","journal-title":"Advanced materials (Deerfield Beach Fla)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-021-00866-8","article-title":"Nanotechnology approaches for global infectious diseases","volume":"16","author":"Kirtane","year":"2021","journal-title":"Nat nanotechnology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2443-1","article-title":"Clinical targeting of HIV-1 capsid protein with a long-acting small molecule","volume":"584","author":"Link","year":"2020","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jconrel.2024.12.052","article-title":"D-peptide hydrogels as a long-acting multipurpose drug delivery platform for combined contraception and HIV-1 prevention","volume":"379","author":"Pentlavalli","year":"2025","journal-title":"J Controlled release: Off J Controlled Release Soc"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.2c00649","article-title":"Next generation gold drugs and probes: chemistry and biomedical applications","volume":"123","author":"Mertens","year":"2023","journal-title":"Chem Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.1039777","article-title":"The success of biomaterial-based tissue engineering strategies for peripheral nerve regeneration","volume":"10","author":"Jiang","year":"2022","journal-title":"Front Bioengineering Biotechnol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00041-24","article-title":"mRNA-based HIV-1 vaccines","volume":"37","author":"Ahmed","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"117395","DOI":"10.1016\/j.bios.2025.117395","article-title":"Nanomechanical systems for the rapid detection of HIV-1 p24 antigen","volume":"280","author":"Samuel","year":"2025","journal-title":"Biosensors bioelectronics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1039\/D5LC00089K","article-title":"A biosensor-integrated filtration device for nanoparticle isolation and label-free imaging","volume":"25","author":"Liu","year":"2025","journal-title":"Lab chip"},{"key":"B28","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/v12090982","article-title":"Advances in continuous microfluidics-based technologies for the study of HIV-1 infection","volume":"12","author":"Eid","year":"2020","journal-title":"Viruses"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05556-6","article-title":"HIV-1 silencing and cell survival signatures in infected T cell reservoirs","volume":"614","author":"Clark","year":"2023","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012206","article-title":"Cell-free assays reveal that the HIV-1 capsid protects reverse transcripts from cGAS immune sensing","volume":"21","author":"Scott","year":"2025","journal-title":"PloS Pathog"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e2417676122","DOI":"10.1073\/pnas.2417676122","article-title":"Macropinosomes are a site of HIV-1 entry into primary CD4(+) T cells","volume":"122","author":"Murakami","year":"2025","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae562","article-title":"Impact of anti-CD4 autoantibodies on immune reconstitution in people with advanced human immunodeficiency virus","volume":"80","author":"Epling","year":"2025","journal-title":"Clin Infect diseases: an Off Publ Infect Dis Soc America"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00230-25","article-title":"The inhibitory receptor LAG3 affects NK cell IFN-\u03b3 production through glycolysis and the PSAT1\/STAT1\/IFNG pathway","volume":"16","author":"Ge","year":"2025","journal-title":"mBio"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1506653","article-title":"Increases in the susceptibility of human endometrial CD4(+) T cells to HIV-1 infection post-menopause are not dependent on greater viral receptor expression frequency","volume":"15","author":"Vom Steeg","year":"2024","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.adq1405","article-title":"A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals","volume":"388","author":"Jobin","year":"2025","journal-title":"Sci (New York NY)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64314","article-title":"Expansion of HIV-specific T follicular helper cells in chronic HIV infection","volume":"122","author":"Lindqvist","year":"2012","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.09.014","article-title":"Alterations of the frequency and functions of follicular regulatory T cells and related mechanisms in HIV infection","volume":"81","author":"Zhao","year":"2020","journal-title":"[J].The J infection"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20240955","article-title":"Shared pathway of WDFY4-dependent cross-presentation of immune complexes by cDC1 and cDC2","volume":"222","author":"Jo","year":"2025","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"105480","DOI":"10.1016\/j.micinf.2025.105480","article-title":"Immunostimulatory effects of Hsp70 fragments-modified DCs: A computational and experimental study in HIV vaccine design","volume":"27","author":"Akbari","year":"2025","journal-title":"Microbes Infection"},{"key":"B40","doi-asserted-by":"publisher","first-page":"103866","DOI":"10.1016\/j.bjid.2024.103866","article-title":"The role of T regulatory cells in the immunopathogenesis of HIV-1: Clinical implications","volume":"28","author":"Esmail Nia","year":"2024","journal-title":"Braz J Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00192","article-title":"Functional mechanisms of treg in the context of HIV-1 infection and the janus face of immune suppression","volume":"7","author":"L\u00f3pez-Abente","year":"2016","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1402074","article-title":"Causal role of immune cells in uveitis: Mendelian randomization study","volume":"15","author":"Wu","year":"2024","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"908314","DOI":"10.1155\/2012\/908314","article-title":"Regulatory T cells in HIV-1 infection: can immunotherapy regulate the regulator","volume":"2012","author":"Jenabian","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"115652","DOI":"10.1016\/j.celrep.2025.115652","article-title":"EZH2 inhibition mitigates HIV-1 immune evasion, reduces reservoir formation, and promotes skewing of CD8(+) T cells toward less-exhausted phenotypes","volume":"44","author":"Gramatica","year":"2025","journal-title":"Cell Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"101398","DOI":"10.1016\/j.coviro.2024.101398","article-title":"Mechanisms of mucosal immunity at the female reproductive tract involved in defense against HIV-1 infection","volume":"66","author":"Choi","year":"2024","journal-title":"Curr Opin Virol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17481","article-title":"Recent advances in CD8(+) T cell-based immune therapies for HIV-1 cure","volume":"9","author":"Arenas","year":"2023","journal-title":"Heliyon"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00575-25","article-title":"Higher proportions of circulating CXCR3+ CCR6- Tfh cells as a hallmark of impaired CD4+ T-cell recovery in HIV-1-infected immunological non-responders","volume":"16","author":"Nagaraju","year":"2025","journal-title":"mBio"},{"key":"B48","doi-asserted-by":"publisher","first-page":"8141","DOI":"10.3390\/ijms25158141","article-title":"Cystatin F Depletion in Mycobacterium tuberculosis-Infected Macrophages Improves Cathepsin C\/Granzyme B-Driven Cytotoxic Effects on HIV-1-Infected Cells during Coinfection","volume":"25","author":"Mandal","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12865-024-00674-4","article-title":"Phenotypic characterization of NK cells in 5-year-old children exposed to maternal HIV-1 and antiretroviral therapy in early-life","volume":"25","author":"Mataramvura","year":"2024","journal-title":". BMC Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012547","article-title":"HIV-1 reservoir and premature aging: risk factors for aging-associated illnesses in adolescents and young adults with perinatally acquired HIV-1","volume":"20","author":"Petrara","year":"2024","journal-title":"PloS Pathog"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.12.007","article-title":"Differential gene expression in CD8(+) cells from HIV-1-infected subjects showing suppression of HIV-1 replication","volume":"362","author":"Martinez-Mari\u00f1o","year":"2007","journal-title":"Virology"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1529721","article-title":"Large-scale screening of HIV-1 T-cell epitopes restricted by 12 prevalent HLA-A allotypes in Northeast Asia and universal detection of HIV-1-specific CD8(+) T cells","volume":"16","author":"Ding","year":"2025","journal-title":"Front Microbiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2400119","article-title":"Tim-3 is required for regulatory T cell-mediated promotion of T cell exhaustion and viral persistence during chronic lymphocytic choriomeningitis virus infection","volume":"213","author":"Nieves-Rosado","year":"2024","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2024.0007","article-title":"Human immunodeficiency virus-human pegivirus coinfected individuals display functional mucosal-associated invariant T cells and follicular T cells irrespective of PD-1 expression","volume":"37","author":"Vimali","year":"2024","journal-title":"Viral Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1468456","article-title":"The molecular mechanisms of CD8(+) T cell responses to SARS-CoV-2 infection mediated by TCR-pMHC interactions","volume":"15","author":"Deng","year":"2024","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41467-024-55544-9","article-title":"CCR5-ligand decorated rilpivirine lipid-based nanoparticles for sustained antiretroviral responses","volume":"16","author":"Patel","year":"2025","journal-title":"Nat Commun"},{"key":"B57","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/v16020288","article-title":"Macrophages: key cellular players in HIV-1 infection and pathogenesis","volume":"16","author":"Woottum","year":"2024","journal-title":"Viruses"},{"key":"B58","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s40001-025-02427-4","article-title":"PD-1 suppression enhances HIV-1 reactivation and T-cell immunity via MAPK\/NF-\u03baB signaling","volume":"30","author":"Lin","year":"2025","journal-title":"Eur J Med Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.cell.2019.04.012","article-title":"Slow delivery immunization enhances HIV neutralizing antibody and germinal center responses via modulation of immunodominance","volume":"177","author":"Cirelli","year":"2019","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1902179116","article-title":"Enhancing humoral immunity via sustained-release implantable microneedle patch vaccination, Proc","volume":"116","author":"Boopathy","year":"2019","journal-title":"Natl Acad Sci USA"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.180771","article-title":"HIV-1 infection and ART exposure affect tumor TCR repertoire of diffuse large B cell lymphoma","volume":"9","author":"Roush","year":"2024","journal-title":"JCI Insight"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat Med"},{"key":"B63","first-page":"6","article-title":"Update of the drug resistance mutations in HIV-1: March 2013","volume":"21","author":"Johnson","year":"2013","journal-title":"Topics Antiviral Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1039\/D4NR00252K","article-title":"Long-circulating nanoparticles as passive targeting nanocarriers for the treatment of thrombosis","volume":"16","author":"Li","year":"2024","journal-title":"Nanoscale"},{"key":"B65","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/17425247.2024.2306138","article-title":"Blood-brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics","volume":"21","author":"Ronaldson","year":"2024","journal-title":"Expert Opin Drug delivery"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1126\/science.1095833","article-title":"Drug delivery systems: entering the mainstream","volume":"303","author":"Allen","year":"2004","journal-title":"Sci (New York NY)"},{"key":"B67","doi-asserted-by":"publisher","first-page":"125166","DOI":"10.1016\/j.ijpharm.2025.125166","article-title":"PEGylated solid lipid nanoparticles for the intranasal delivery of combination antiretroviral therapy composed of Atazanavir and Elvitegravir to treat NeuroAIDS","volume":"670","author":"Bazargani","year":"2025","journal-title":"Int J pharmaceutics"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.1c00916","article-title":"Lipid-nanoparticle-based delivery of CRISPR\/cas9 genome-editing components","volume":"19","author":"Kazemian","year":"2022","journal-title":"Mol pharmaceutics"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3390\/pharmaceutics12111114","article-title":"Optimising PLGA-PEG nanoparticle size and distribution for enhanced drug targeting to the inflamed intestinal barrier","volume":"12","author":"Mohan","year":"2020","journal-title":"Pharmaceutics"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nature02388","article-title":"Designing materials for biology and medicine","volume":"428","author":"Langer","year":"2004","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.06.004","article-title":"Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs","volume":"29","author":"Tomb\u00e1cz","year":"2021","journal-title":"Mol therapy: J Am Soc Gene Ther"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.7150\/thno.33925","article-title":"Extracellular vesicles expressing a single-chain variable fragment of an hiv-1 specific antibody selectively target env+ Tissues","volume":"9","author":"Zou","year":"2019","journal-title":"Theranostics"},{"key":"B73","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1038\/s41467-021-25839-2","article-title":"Exosome-mediated stable epigenetic repression of hiv-1","volume":"12","author":"Shrivastava","year":"2021","journal-title":"Nat Commun"},{"key":"B74","doi-asserted-by":"publisher","first-page":"a3172","DOI":"10.1136\/bmj.a3172","article-title":"HIV-1 infection, antiretroviral treatment, ageing, and non-AIDS related morbidity","volume":"338","author":"Deeks","year":"2009","journal-title":"BMJ (Clinical Res ed)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-023-01349-3","article-title":"Monocyte-derived macrophages contain persistent latent HIV-1 reservoirs","volume":"8","author":"Veenhuis","year":"2023","journal-title":"Nat Microbiol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"727241","DOI":"10.1155\/2011\/727241","article-title":"Targeted liposomal drug delivery to monocytes and macrophages","volume":"2011","author":"Kelly","year":"2011","journal-title":"J Drug delivery"},{"key":"B77","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal transduction targeted Ther"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/ph15101283","article-title":"Strategies for improving peptide stability and delivery","volume":"15","author":"Al Musaimi","year":"2022","journal-title":"Pharm (Basel Switzerland)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.12.022","article-title":"An update on oral drug delivery via intestinal lymphatic transport","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.12843","article-title":"Metabolically active CD4+ T cells expressing Glut1 and OX40 preferentially harbor HIV-1 during in vitro infection","volume":"591","author":"Palmer","year":"2017","journal-title":"FEBS Lett"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1477878","article-title":"The isolation, bioactivity, and synthesis of natural products from Litsea verticillate with anti-HIV-1 activities","volume":"15","author":"Yan","year":"2024","journal-title":"Front Pharmacol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-025-05823-1","article-title":"A dual-mode RNA-splitting aptamer biosensor for sensitive HIV-1 Tat peptide detection via colorimetry and fluorescence","volume":"417","author":"Huang","year":"2025","journal-title":"Analytical bioanalytical Chem"},{"key":"B83","doi-asserted-by":"publisher","first-page":"124173","DOI":"10.1016\/j.ijbiomac.2023.124173","article-title":"Advances in aptamer-mediated targeted delivery system for cancer treatment","volume":"238","author":"He","year":"2023","journal-title":"Int J Biol macromolecules"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.2174\/1567201818666210609161301","article-title":"Targeted drug delivery: trends and perspectives","volume":"18","author":"Ashique","year":"2021","journal-title":"Curr Drug delivery"},{"key":"B85","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/polym9040137","article-title":"pH sensitive hydrogels in drug delivery: brief history, properties, swelling, and release mechanism, material selection and applications","volume":"9","author":"Rizwan","year":"2017","journal-title":"Polymers"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23649","article-title":"Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel","volume":"102","author":"Ju","year":"2013","journal-title":"J Pharm Sci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"105533","DOI":"10.1016\/j.ebiom.2024.105533","article-title":"SHMT2 regulates CD8+ T cell senescence via the reactive oxygen species axis in HIV-1 infected patients on antiretroviral therapy","volume":"112","author":"Zhang","year":"2025","journal-title":"EBioMedicine"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.08.034","article-title":"Redox-responsive nano-carriers as tumor-targeted drug delivery systems","volume":"157","author":"Raza","year":"2018","journal-title":"Eur J medicinal Chem"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4181","article-title":"Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery","volume":"36","author":"Tang","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.3c14908","article-title":"Cell-penetrating and enzyme-responsive peptides for targeted cancer therapy: role of arginine residue length on cell penetration and in vivo systemic toxicity","volume":"16","author":"Ghaemi","year":"2024","journal-title":"ACS Appl materials interfaces"},{"key":"B91","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.3390\/ijms23084421","article-title":"Enzyme-responsive hydrogels as potential drug delivery systems-state of knowledge and future prospects","volume":"23","author":"Sobczak","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.4c00385","article-title":"Breaking the cycle: matrix metalloproteinase inhibitors as an alternative approach in managing tuberculosis pathogenesis and progression","volume":"10","author":"Jhilta","year":"2024","journal-title":"ACS Infect Dis"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2022.2072413","article-title":"PLGA sustained-release microspheres loaded with an insoluble small-molecule drug: microfluidic-based preparation, optimization, characterization, and evaluation in vitro and in vivo","volume":"29","author":"Su","year":"2022","journal-title":"Drug delivery"},{"key":"B94","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/polym17050661","article-title":"Effect of poly (Caprolactone) introduction site on the network structure and properties of glycidyl azide polymer adhesive","volume":"17","author":"Tu","year":"2025","journal-title":"Polymers"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202502939","article-title":"Optimally aligned nerve scaffolds with sustained astaxanthin release improve the inflammatory microenvironment through mitophagy activation","volume":"21","author":"Jin","year":"2025","journal-title":"Small (Weinheim an der Bergstrasse Germany)"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30340-4","article-title":"Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study","volume":"8","author":"Orkin","year":"2021","journal-title":"Lancet HIV-1"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.5c03798","article-title":"MXene-based microneedle electrode for brain-computer interface in diverse scenarios","volume":"17","author":"Chen","year":"2025","journal-title":"ACS Appl materials interfaces"},{"key":"B98","doi-asserted-by":"publisher","first-page":"125232","DOI":"10.1016\/j.ijbiomac.2023.125232","article-title":"Exosome-loaded microneedle patches: Promising factor delivery route","volume":"243","author":"Fathi-Karkan","year":"2023","journal-title":"Int J Biol macromolecules"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2023.1125159","article-title":"Microarray patch for HIV-1 prevention and as a multipurpose prevention technology to prevent HIV-1 and unplanned pregnancy: an assessment of potential acceptability, usability, and programmatic fit in Kenya","volume":"5","author":"Gachigua","year":"2023","journal-title":"Front Reprod Health"},{"key":"B100","doi-asserted-by":"publisher","first-page":"106220","DOI":"10.1016\/j.ijantimicag.2020.106220","article-title":"Long-acting drugs and formulations for the treatment and prevention of HIV-1 infection","volume":"57","author":"Flexner","year":"2021","journal-title":"Int J Antimicrobial Agents"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201300583","article-title":"Morphologically virus-like fullerenol nanoparticles act as the dual-functional nanoadjuvant for HIV-1 vaccine","volume":"25","author":"Xu","year":"2013","journal-title":"Adv Mater"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.05.028","article-title":"Dimier-Poisson Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination","volume":"27","author":"Aline","year":"2009","journal-title":"Vaccine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1670423\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T05:29:47Z","timestamp":1756704587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1670423\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":102,"alternative-id":["10.3389\/fimmu.2025.1670423"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1670423","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"article-number":"1670423"}}